President Trump on Thursday night launched TrumpRx, the website he and his aides have touted as a platform aimed at lowering drug prices ...
Roivant and its spinout Priovant said this morning that their immune-modifying drug significantly outperformed placebo in clearing lesions caused by a rare skin disease in a small trial.
The Environmental Working Group, an advocacy group, slammed the announcement as a “retreat” from health secretary Kennedy’s promise to ban synthetic food dyes altogether.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results